EVOLUS, INC. (EOLS) ROA
- 2026-06-30: ROA -13.84%.
- 2026-03-31: ROA -19.68%.
- 2025-12-31: ROA -22.86%.
- 2025-09-30: ROA -26.74%.
Complete source-backed roa history.
- Available history
- 2017-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|
| 2026-06-30 | -13.84% |
|---|
| 2026-03-31 | -19.68% |
|---|
| 2025-12-31 | -22.86% |
|---|
| 2025-09-30 | -26.74% |
|---|
| 2025-06-30 | -27.10% |
|---|
| 2025-03-31 | -26.34% |
|---|
| 2024-12-31 | -21.68% |
|---|
| 2024-09-30 | -24.15% |
|---|
| 2024-06-30 | -22.76% |
|---|
| 2024-03-31 | -26.53% |
|---|
| 2023-12-31 | -32.64% |
|---|
| 2023-09-30 | -37.52% |
|---|
| 2023-06-30 | -39.28% |
|---|
| 2023-03-31 | -44.75% |
|---|
| 2022-12-31 | -41.81% |
|---|
| 2022-09-30 | -41.21% |
|---|
| 2022-06-30 | -37.26% |
|---|
| 2022-03-31 | -32.05% |
|---|
| 2021-12-31 | -18.18% |
|---|
| 2021-09-30 | -64.74% |
|---|
| 2021-06-30 | -54.76% |
|---|
| 2021-03-31 | -87.07% |
|---|
| 2020-12-31 | -77.97% |
|---|
| 2020-09-30 | -30.97% |
|---|
| 2020-06-30 | -42.33% |
|---|
| 2020-03-31 | -46.13% |
|---|
| 2019-12-31 | -37.45% |
|---|
| 2019-09-30 | -48.16% |
|---|
| 2019-06-30 | -35.91% |
|---|
| 2019-03-31 | -23.39% |
|---|
| 2018-12-31 | -27.27% |
|---|
| 2018-09-30 | -16.35% |
|---|
| 2018-06-30 | -17.04% |
|---|
| 2018-03-31 | -5.22% |
|---|
| 2017-12-31 | -2.94% |
|---|
Annual ROA
| Date | ROA |
|---|
| 2025-12-31 | -22.86% |
|---|
| 2024-12-31 | -21.68% |
|---|
| 2023-12-31 | -32.64% |
|---|
| 2022-12-31 | -41.81% |
|---|
| 2021-12-31 | -18.18% |
|---|
| 2020-12-31 | -77.97% |
|---|
| 2019-12-31 | -37.45% |
|---|
| 2018-12-31 | -27.27% |
|---|
| 2017-12-31 | -2.94% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
|---|
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
|---|
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
|---|